Advertisement

Annals of Surgical Oncology

, Volume 11, Supplement 3, pp 203S–207S | Cite as

Sentinel lymph node dissection and lymphatic mapping for local subcutaneous recurrence in melanoma treatment: Longer-term follow-up results

  • Brendon J. Coventry
  • Barry Chatterton
  • Fergus Whitehead
  • Craig James
  • P. Grantley Gill
Article

Abstract

Lymphatic mapping and sentinel lymph node dissection (LM/SLND) for surgical staging of cutaneous primary melanoma is currently being evaluated, but the role of these techniques in recurrent (secondary) melanoma is largely unexplored. Our experience with 12 patients indicates the potential usefulness of LM/SLND in the management of locally recurrent melanoma at subcutaneous sites. We have even used mapping to localize the sentinel node draining a subcutaneous local recurrence after previous LM/SLND for primary melanoma. The application of LM/SLND may therefore be extended beyond primary melanoma management as we understand more about the technical issues and appropriate selection of patients.

Key Words

Lymphatic mapping Seeondary Sentinel node biopsy Subcutaneous melanoma recurrence 

References

  1. 1.
    Morton DL, Wen D-R, Wong JH, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma.Arch Surg 1992;127:392–9.PubMedGoogle Scholar
  2. 2.
    Kollias J, Gill PG, Chatterton BE, et al. Reliability of sentinel node biopsy in predicting axillary node involvement in breast cancer.Med J Aust 1999;171:461–5.PubMedGoogle Scholar
  3. 3.
    Morton DL, Thompson JF, Essner R, et al. Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymph-adenectomy for early-stage melanoma: a multicenter trial.Ann Surg 1999;230:453–63.PubMedCrossRefGoogle Scholar
  4. 4.
    Uren RF, Thompson JF, Howman-Giles RB.Lymphatic Drainage of the Skin and Breast: Locating the Sentinel Nodes. Amsterdam: Harwood Academic Publishers, 1999.Google Scholar
  5. 5.
    Thompson JF, Uren RF, Shaw HM, et al. The location of the sentinel lymph node in cutaneous melanoma: new insights into lymphatic anatomy.J Am Coll Surg 1999;189:195–206.PubMedCrossRefGoogle Scholar
  6. 6.
    Uren RF, Howman-Giles RB, Thompson JF, et al. Lymphoscin-tigraphy to identify sentinel nodes in patients with melanoma.Melanoma Res 1994;4:395–9.PubMedCrossRefGoogle Scholar
  7. 7.
    Thompson JF, Uren RF, Coventry BJ, Chatterton B. Lymphoscintigraphy. In: Balch CM, Houghton AN, Sober AJ, Soong SJ, eds.Cutaneous Melanoma. 4th ed. St. Louis: Quality Medical Publishing, 2003.Google Scholar
  8. 8.
    Balch CM, Buzaid AC, Soong SJ, et al. Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma.J Clin Oncol 2001;19:3635–48.PubMedGoogle Scholar
  9. 9.
    Balch CM, Houghton AN, Sober AJ, Soong SJ, eds.Cutaneous Melanoma. 4th ed. St. Louis: Quality Medical Publishing, 2003: 40.Google Scholar

Copyright information

© The Society of Surgical Oncology, Inc. 2004

Authors and Affiliations

  • Brendon J. Coventry
    • 1
  • Barry Chatterton
    • 2
  • Fergus Whitehead
    • 3
  • Craig James
    • 3
  • P. Grantley Gill
    • 1
  1. 1.Adelaide Melanoma Unit and Breast Endocrine and Surgical Oncology Unit Department of Surgery, University of AdelaideRoyal Adelaide HospitalAdelaideAustralia
  2. 2.Department of Nuclear MedicineRoyal Adelaide HospitalAdelaideAustralia
  3. 3.Department of PathologyInstitute of Medical and Veterinary Sciences, and Adelaide Pathology PartnersAdelaide

Personalised recommendations